Author:
DiBartolomeo Alexander D.,Rowe Vincent L.
Subject
Cardiology and Cardiovascular Medicine,Surgery
Reference40 articles.
1. Part II, 1938, Food, Drug, and Cosmetic Act. US Food and Drug Administration. Accessed January 5, 2023. https://www.fda.gov/about-fda/changes-science-law-and-regulatory-authorities/part-ii-1938-food-drug-cosmetic-act.
2. Racial differences in response to therapy for heart failure: analysis of the vasodilator-heart failure trials. Vasodilator-Heart Failure Trial Study Group;Carson;J Card Fail,1999
3. National Institutes of Health Revitalization Act of 1993: Act to Amend the Public Health Service Act to Revise and Extend the Progras of the National Institutes of Health, and for Other Purposes. Pub. L. No.103-43 (June 20, 1993).
4. Twenty years post-NIH Revitalization Act: enhancing minority participation in clinical trials (EMPaCT): laying the groundwork for improving minority clinical trial accrual: renewing the case for enhancing minority participation in cancer clinical trials;Chen;Cancer,2014
5. Dialogues on diversifying clinical trials: successful strategies for engaging women and minorities in clinical trials;Coakley;J Womens Health (Larchmt),2012